Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1166742 | 0.97 | KMT2A (0.40) | KMT2AMAPTLMNAKDM4EMEN1 | |
| SCHEMBL11553771 | 0.94 | MAPT (0.44) | KMT2AMAPTLMNATDP1FAAH | |
| SCHEMBL540009 | 0.94 | LMNA (0.39) | KMT2AMAPTLMNAKDM4EMEN1 | |
| SCHEMBL3218037 | 0.88 | — | — | |
| SCHEMBL3227163 | 0.85 | — | — | |
| SCHEMBL11343890 | 0.85 | — | — | |
| SCHEMBL11245058 | 0.84 | TSHR (0.60) | KMT2AMAPTLMNAMEN1ALDH1A1 | |
| SCHEMBL28466238 | 0.82 | FAAH (0.52) | KMT2AMAPTLMNAKDM4EMEN1 | |
| SCHEMBL14284057 | 0.82 | TSHR (0.38) | KMT2AMAPTLMNATDP1FAAH | |
| SCHEMBL14284065 | 0.82 | TSHR (0.38) | KMT2AMAPTLMNATDP1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060115695-A1 | Bisphenol compound and aromatic polyaryl ether | UBE INDUSTRIES, LTD. (JP) | 2006-06-01 | — | — | US | disclosed |
| EP-0431605-A2 | 1-Azabicyclo[m.n.O]alkane derivatives, their salts and process for preparing them | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1991-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060115695-A1 | Bisphenol compound and aromatic polyaryl ether | ARSA, EP300, PAH | KMT2A 505/4885MAPT 4080/4885LMNA 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.